Substance active (DCI)
- nifédipine
- lidocaïne chlorhydrate
Informations techniques
Exploitant
LABORATOIRES LEURQUIN MEDIOLANUM SAS
Présentation
NIFEXINE,0,3 g/1,50 g, crème rectale
1 tube(s) aluminium de 30 g avec canule endorectale en polyéthylène basse densité (PEBD) (CIP : 34009 302 010 1 5)
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
8pPQk3af6QnFeD3Z
Écouter
Français